Solana Financials - Benzinga

Solana Co

HSDTNASDAQ

Trade with Public

Trade with Public

$2.91

-0.36-10.97%

Dern. MÀJ: Sep 23, 1:12 PM

Aperçu Actualités Prévisions de résultats Événements Objectifs de coursDonnées financièresSentiment Actionnariat Comparer Options Rapport sur les stocks

Solana Financials

Solana (HSDT) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Helius Medical Tech Q2 EPS $(0.38) Misses $(0.07) Estimate, Sales $2.526M Miss $3.600M Estimate

Helius Medical Tech (NASDAQ:HSDT) reported quarterly losses of $(0.38) per share which missed the analyst consensus estimate of $(0.07) by 442.86 percent. This is a 99.52 percent increase over losses of $(79.73) per

Benzinga Newsdesk

PRO
Helius Medical Tech Q1 EPS $(1.30) Misses $(0.48) Estimate, Sales $3.620M Beat $3.400M Estimate

Helius Medical Tech (NASDAQ:HSDT) reported quarterly losses of $(1.30) per share which missed the analyst consensus estimate of $(0.48) by 170.83 percent. This is a 99.66 percent increase over losses of $(382.50) per

Benzinga Newsdesk

Earnings Scheduled For May 15, 2026

Benzinga Insights

PRO
Helius Medical Tech Q4 EPS $4.25, Sales $5.228M

Benzinga Newsdesk

Earnings Scheduled For March 30, 2026

Benzinga Insights

PRO
Helius Medical Tech Q3 EPS $(32.89) Beats $(50.50) Estimate, Sales $697.000K Beat $110.000K Estimate

Helius Medical Tech (NASDAQ:HSDT) reported quarterly losses of $(32.89) per share which beat the analyst consensus estimate of $(50.50) by 34.87 percent. This is a 95.57 percent increase over losses of $(742.50) per

Benzinga Newsdesk

© 2026 Benzinga | All Rights Reserved